newsfilter
← Latest News
Business Wire·

Alpine Immune Sciences Announces Participation in the Bank of America Securities Healthcare Conference

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced that the Company will